Peter Kim, Exe V-P & Pres, MRL at Merck & Company, holds 62.94K shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 190.96K shares in Merck & Company (Ticker: MRK). Most recently, Peter Kim Bought ― shares of Entrada Therapeutics Inc on Apr 10, 2024 for an estimated value of 35.28K.